# BKV Corp: financial statements, quarterly

BKV · NYSE · CIK 1838406 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkv.md) · [Financials](/companies/bkv/financials.md) · [Filings](/companies/bkv/filings.md) · [Insiders](/companies/bkv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkv/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [182](/filings/0001628280-24-047546.md) | [458 d](/filings/0001104659-26-098821.md) | [156](/filings/0001628280-25-024150.md) | [134](/filings/0001628280-25-039839.md) | [133](/filings/0001628280-25-051049.md) | [386 d](/filings/0001104659-26-098821.md) | [272](/filings/0001628280-26-032241.md) | [269](/filings/0001628280-26-054162.md) | [200](/filings/0001628280-25-051049.md) | [505 d](/filings/0001104659-26-098821.md) | [377](/filings/0001628280-26-032241.md) | [322](/filings/0001628280-26-054162.md) |
| Operating income | $m | [(5.3)](/filings/0001628280-24-047546.md) | [142 d](/filings/0001104659-26-098821.md) | [(34.4)](/filings/0001628280-25-024150.md) | [(43.2)](/filings/0001628280-25-039839.md) | [(21.0)](/filings/0001628280-25-051049.md) | [34.3 d](/filings/0001104659-26-098821.md) | [(100)](/filings/0001628280-26-032241.md) | [161](/filings/0001628280-26-054162.md) | [82.3](/filings/0001628280-25-051049.md) | [187 d](/filings/0001104659-26-098821.md) | [86.0](/filings/0001628280-26-032241.md) | [122](/filings/0001628280-26-054162.md) |
| Income tax | $m | [5.2](/filings/0001628280-24-047546.md) | [7.1 d](/filings/0001104659-26-098821.md) | [(13.0)](/filings/0001628280-25-024150.md) | [(28.4)](/filings/0001628280-25-039839.md) | [11.3](/filings/0001628280-25-051049.md) | [(12.4) d](/filings/0001104659-26-098821.md) | [(30.7)](/filings/0001628280-26-032241.md) | [29.2](/filings/0001628280-26-054162.md) | [20.0](/filings/0001628280-25-051049.md) | [18.1 d](/filings/0001104659-26-098821.md) | [11.5](/filings/0001628280-26-032241.md) | [20.2](/filings/0001628280-26-054162.md) |
| Net income | $m | [18.6](/filings/0001628280-24-047546.md) | [44.2 d](/filings/0001104659-26-098821.md) | [(38.6)](/filings/0001628280-25-039839.md) | [(59.7)](/filings/0001628280-25-039839.md) | [12.9](/filings/0001628280-25-051049.md) | [(53.2) d](/filings/0001104659-26-098821.md) | [(82.0)](/filings/0001628280-26-032241.md) | [108](/filings/0001628280-26-054162.md) | [76.9](/filings/0001628280-25-051049.md) | [76.4 d](/filings/0001104659-26-098821.md) | [44.1](/filings/0001628280-26-032241.md) | [75.8](/filings/0001628280-26-054162.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001628280-24-047546.md) | not reported | [(0.58)](/filings/0001628280-25-024150.md) | [(0.90)](/filings/0001628280-25-039839.md) | [0.18](/filings/0001628280-25-051049.md) | not reported | [(0.97)](/filings/0001628280-26-032241.md) | [1.27](/filings/0001628280-26-054162.md) | [0.90](/filings/0001628280-25-051049.md) | not reported | [0.42](/filings/0001628280-26-032241.md) | [0.67](/filings/0001628280-26-054162.md) |
| Basic EPS | $ per share | [0.31](/filings/0001628280-24-047546.md) | not reported | [(0.58)](/filings/0001628280-25-024150.md) | [(0.90)](/filings/0001628280-25-039839.md) | [0.19](/filings/0001628280-25-051049.md) | not reported | [(0.97)](/filings/0001628280-26-032241.md) | [1.27](/filings/0001628280-26-054162.md) | [0.90](/filings/0001628280-25-051049.md) | not reported | [0.42](/filings/0001628280-26-032241.md) | [0.68](/filings/0001628280-26-054162.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [54.1](/filings/0001628280-24-047546.md) | [105](/filings/0001104659-26-098821.md) | not reported | not reported | [31.3](/filings/0001628280-24-047546.md) | [81.2](/filings/0001104659-26-098821.md) | [15.3](/filings/0001628280-25-024150.md) | [21.4](/filings/0001628280-25-039839.md) | [83.1](/filings/0001628280-25-051049.md) | [248](/filings/0001104659-26-098821.md) | [289](/filings/0001628280-26-032241.md) | [152](/filings/0001628280-26-054162.md) |
| Current assets | $m | not reported | [312](/filings/0001628280-25-015622.md) | not reported | not reported | [126](/filings/0001628280-24-047546.md) | [235](/filings/0001104659-26-098821.md) | [105](/filings/0001628280-25-024150.md) | [98.4](/filings/0001628280-25-039839.md) | [202](/filings/0001628280-25-051049.md) | [511](/filings/0001104659-26-098821.md) | [568](/filings/0001628280-26-032241.md) | [458](/filings/0001628280-26-054162.md) |
| Total assets | $m | not reported | [2,683](/filings/0001628280-25-015622.md) | not reported | not reported | [2,268](/filings/0001628280-24-047546.md) | [3,099](/filings/0001104659-26-098821.md) | [3,124](/filings/0001628280-26-032241.md) | [3,166](/filings/0001628280-26-054162.md) | [2,892](/filings/0001628280-25-051049.md) | [3,939](/filings/0001104659-26-098821.md) | [4,172](/filings/0001628280-26-032241.md) | [4,235](/filings/0001628280-26-054162.md) |
| Current liabilities | $m | not reported | [412](/filings/0001628280-25-015622.md) | not reported | not reported | [139](/filings/0001628280-24-047546.md) | [237](/filings/0001104659-26-098821.md) | [254](/filings/0001628280-25-024150.md) | [175](/filings/0001628280-25-039839.md) | [236](/filings/0001628280-25-051049.md) | [565](/filings/0001104659-26-098821.md) | [433](/filings/0001628280-26-032241.md) | [399](/filings/0001628280-26-054162.md) |
| Total liabilities | $m | not reported | [1,205](/filings/0001628280-25-015622.md) | not reported | not reported | [668](/filings/0001628280-24-047546.md) | [1,546](/filings/0001104659-26-098821.md) | [769](/filings/0001628280-25-024150.md) | [716](/filings/0001628280-25-039839.md) | [1,086](/filings/0001628280-25-051049.md) | [1,873](/filings/0001104659-26-098821.md) | [1,860](/filings/0001628280-26-032241.md) | [1,832](/filings/0001628280-26-054162.md) |
| Long-term debt | $m | not reported | [579](/filings/0001628280-25-015622.md) | not reported | not reported | [190](/filings/0001628280-24-047546.md) | [850](/filings/0001104659-26-098821.md) | [200](/filings/0001628280-25-024150.md) | [200](/filings/0001628280-25-039839.md) | [487](/filings/0001628280-25-051049.md) | [938](/filings/0001104659-26-098821.md) | [1,081](/filings/0001628280-26-032241.md) | [1,064](/filings/0001628280-26-054162.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [9.4](/filings/0001104659-26-098821.md) | not reported | not reported | [0.0](/filings/0001628280-25-051049.md) | [200](/filings/0001104659-26-098821.md) | [185](/filings/0001628280-26-032241.md) | [185](/filings/0001628280-26-054162.md) |
| Shareholders' equity | $m | [1,296](/filings/0001628280-24-047546.md) | [1,291](/filings/0001628280-25-039839.md) | [1,250](/filings/0001628280-25-039839.md) | [1,192](/filings/0001628280-25-039839.md) | [1,599](/filings/0001628280-24-047546.md) | [1,501](/filings/0001104659-26-098821.md) | [1,482](/filings/0001628280-25-039839.md) | [1,590](/filings/0001628280-25-039839.md) | [1,793](/filings/0001628280-25-051049.md) | [1,986](/filings/0001104659-26-098821.md) | [2,212](/filings/0001628280-26-032241.md) | [2,297](/filings/0001628280-26-054162.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [145 d](/filings/0001104659-26-098821.md) | [19.3](/filings/0001628280-25-024150.md) | [(9.5) d](/filings/0001628280-25-039839.md) | [65.0 d](/filings/0001628280-25-051049.md) | [40.6 d](/filings/0001104659-26-098821.md) | [16.5](/filings/0001628280-26-032241.md) | [89.3 d](/filings/0001628280-26-054162.md) | [67.6 d](/filings/0001628280-25-051049.md) | [107 d](/filings/0001104659-26-098821.md) | [72.0](/filings/0001628280-26-032241.md) | [110 d](/filings/0001628280-26-054162.md) |
| Capital expenditure | $m | not reported | not reported | not reported | [52.8 d](/filings/0001628280-25-051049.md) | [52.6 d](/filings/0001104659-26-098821.md) | [57.6](/filings/0001628280-26-032241.md) | [66.5 d](/filings/0001628280-26-054162.md) | [84.9 d](/filings/0001628280-25-051049.md) | [96.2 d](/filings/0001104659-26-098821.md) | [107](/filings/0001628280-26-032241.md) | [86.8 d](/filings/0001628280-26-054162.md) |
| Share repurchases | $m | [0.2 d](/filings/0001104659-26-098821.md) | not reported | not reported | not reported | [(2.1) d](/filings/0001628280-25-015622.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.2](/filings/0001628280-24-047546.md) | [66.3](/filings/0001628280-25-024150.md) | [66.3](/filings/0001628280-25-039839.md) | [70.6](/filings/0001628280-25-051049.md) | [84.7](/filings/0001628280-26-032241.md) | [84.8](/filings/0001628280-26-054162.md) | [85.0](/filings/0001628280-25-051049.md) | [102](/filings/0001628280-26-032241.md) | [110](/filings/0001628280-26-054162.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 109,437,830 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054162.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.